Effects of Pregnancy for Cystic Fibrosis Patients

 

Trial Objective

Effects of Pregnancy for CF PatientsA national research study called MAYFLOWERS wants to understand the changes of lung function in pregnant women with cystic fibrosis (CF) during pregnancy and 2 years after delivery. It also looks at the health of their babies. Additionally, if women are taking any Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator, including TRIKAFTA®, the study will look at the effect of modulator on the health of mother and baby.

Enrollment

Active Clinical Trials Currently Recruiting

Who Can Participate

Pregnant women with cystic fibrosis.
 

Age: 16+    Gender: Any Gender


Estimated Time Commitment

7 to 9 clinic visits

Up to three visits during pregnancy and up to six visits over the two years after delivery.



Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Available

Trial Contact

For more information, contact:

Renee Plomondon

Renee Plomondon
303.370.2598

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

TDN

Principal Investigators


Request More Information

By completing this form, you agree to learn more about this study and see if you qualify.


*
*
*
*
 I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: